Natco Pharma reports 52% fall in Q3 consolidated net profit

12 Feb 2015 Evaluate

Natco Pharma has reported results for third quarter ended December 31, 2014.

The company has registered a fall of 48.77% in its net profit after tax at Rs 16.61 crore for the quarter under review as compared to Rs 32.42 crore for the same quarter in the previous year. Total income of the company has decreased 0.68% at Rs 174.08 crore for Q3FY15 as compared Rs 175.28 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit after tax, share of minority interest and share of profit/(loss) of associates declined 52.01% to Rs 14.34 crore for the Q3 FY15 as compared to Rs 29.88 crore in Q3 FY14. The total income decreased 0.89% to Rs 202.80 crore in the quarter under review as compared to Rs 204.63 crore in the corresponding quarter previous year.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×